ReviewRAAS, ACE2 and COVID-19; a mechanistic review
Under a Creative Commons license
open access
Keywords
COVID-19
ACE2
Angiotensin II
Angiotensin 1–7
ACEIs
ARBs
Abbreviations
ACE1
angiotensin-converting enzyme 1
ACE2
angiotensin-converting enzyme 2
ACEIs
angiotensin-converting enzyme inhibitors
AEC-II
alveolar epithelial type II cells
Ang 1-7
angiotensin 1-7
Ang 1-9
angiotensin 1-9
AngI
angiotensin I
AngII
angiotensin II
ARBs
angiotensin receptor blockers
AT1R
angiotensin type 1 receptor
AT2R
angiotensin type 2 receptor
COVID-19
coronavirus disease 2019
CVD
cardiovascular disease
ERK
extracellular signal-regulated kinase
ICU
intensive care unit
MAPK
mitogen-activated protein kinase
miR-21
microRNA-21
NLRP3
(NOD, LRR, and pyrin domain-containing protein 3)
RAAS
renin-angiotensin-aldosterone system
TGF-β
transforming growth factor-beta
Cited by (0)
Peer review under responsibility of King Saud University.
© 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.